We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBUU icon
2151
Malibu Boats
MBUU
$576M
$740K ﹤0.01%
12,764
+1,711
+15% +$110K
SPWR
2152
DELISTED
SunPower Corporation Common Stock
SPWR
$740K ﹤0.01%
34,471
+4,606
+15% +$84.6K
RVNC
2153
DELISTED
Revance Therapeutics, Inc.
RVNC
$739K ﹤0.01%
37,904
+5,551
+17% +$84.2K
EPIX
2154
DELISTED
ESSA Pharma
EPIX
$738K ﹤0.01%
+119,451
New +$1.05M
BUSE icon
2155
First Busey Corp
BUSE
$2.58B
$736K ﹤0.01%
29,039
+4,097
+16% +$113K
UTAAU
2156
DELISTED
UTA Acquisition Corporation Units
UTAAU
$735K ﹤0.01%
73,500
REPX icon
2157
Riley Exploration Permian
REPX
$796M
$732K ﹤0.01%
+29,182
New +$783K
SRG
2158
Seritage Growth Properties
SRG
$131M
$732K ﹤0.01%
57,793
+7,826
+16% +$86.3K
ANGO icon
2159
AngioDynamics
ANGO
$647M
$731K ﹤0.01%
33,955
-5,186
-13% -$118K
GABC icon
2160
German American Bancorp
GABC
$1.91B
$728K ﹤0.01%
19,164
+574
+3% +$22.9K
GTY
2161
Getty Realty Corp
GTY
$2.04B
$728K ﹤0.01%
25,425
+936
+4% +$27K
NMIH icon
2162
NMI Holdings
NMIH
$3.38B
$727K ﹤0.01%
35,271
+7,889
+29% +$184K
CYBR
2163
DELISTED
CyberArk
CYBR
$726K ﹤0.01%
4,301
+600
+16% +$91K
KAMN
2164
DELISTED
Kaman Corp
KAMN
$725K ﹤0.01%
16,672
-2,160
-11% -$91.5K
MTRN icon
2165
Materion
MTRN
$5.9B
$720K ﹤0.01%
8,400
-891
-10% -$76.2K
TWOU
2166
DELISTED
2U Inc
TWOU
$720K ﹤0.01%
1,808
+380
+27% +$153K
DGRO icon
2167
iShares Core Dividend Growth ETF
DGRO
$43.9B
$718K ﹤0.01%
13,439
BEP icon
2168
Brookfield Renewable
BEP
$10.3B
$717K ﹤0.01%
17,456
-1,922
-10% -$68.9K
ACI icon
2169
Albertsons Companies
ACI
$5.83B
$716K ﹤0.01%
21,529
+6,263
+41% +$195K
NTCT icon
2170
NETSCOUT
NTCT
$2.87B
$716K ﹤0.01%
22,334
+1,488
+7% +$46.8K
DNB
2171
DELISTED
Dun & Bradstreet
DNB
$713K ﹤0.01%
40,722
+9,016
+28% +$168K
OPI
2172
DELISTED
Office Properties Income Trust
OPI
$713K ﹤0.01%
27,710
+1,093
+4% +$27.8K
DLX icon
2173
Deluxe
DLX
$1.09B
$710K ﹤0.01%
23,472
-68
-0.3% -$2.14K
TCBK icon
2174
TriCo Bancshares
TCBK
$1.84B
$709K ﹤0.01%
17,724
+535
+3% +$23.2K
NFE icon
2175
New Fortress Energy
NFE
$93M
$708K ﹤0.01%
16,621
+1,221
+8% +$32.9K

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.